These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Immune modulatory and therapeutical effect of shenqi tablet accessory therapy in treating recurrent genital herpes].
    Author: Yu JB, Yin GW, He QB.
    Journal: Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Nov; 21(11):831-3. PubMed ID: 12575377.
    Abstract:
    OBJECTIVE: To observe the immune modulatory and therapeutical effect of Shenqi tablet (SQT) in treating recurrent genital herpes. METHODS: Sixty-three patients were randomly divided into two groups, the SQT group (34 cases) and the control group (29 cases). The immunologic function of patients was determined before and after treatment and the recurrence rate of two groups was compared. RESULTS: In the SQT group after treatment, CD3, CD4 and CD4/CD8 ratio raised, CD8 percent lowered, serum interleukin 2 (SIL-2) and RBC-C3b raised and serum SIL-2 receptor lowered (all P < 0.05), while in the control group, the above-mentioned parameters were not changed significantly. Follow-up conducted 6 months after treatment showed that the recurrence rate in the SQT group was 26.5% (9 cases), which was lower than that in the control group (72.4%, 21 cases) significantly (P < 0.01). CONCLUSION: SQT has immune modulatory effect in patients with recurrent genital herpes, it could reduce the recurrence rate.
    [Abstract] [Full Text] [Related] [New Search]